NNVC is a development stage biotechnology company. We bought it when it's market cap was about $10M. Today it's market cap is about $50M, but it may be in a better risk:reward stance then it was at the $10M valuation.
Why? Hit these links:
(1) Recent interview with CEO.
(2) Summary of salient points posted on iHub.